These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20648587)

  • 61. Cervical nodal metastases of unresectable thoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after concurrent chemoradiotherapy.
    Liu H; Lu L; Zhu Q; Hao Y; Mo Y; Liu M; Hu Y; Cui N; Rong T
    Radiother Oncol; 2011 May; 99(2):181-6. PubMed ID: 21620504
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy.
    Aiko S; Yoshizumi Y; Ishizuka T; Sakano T; Kumano I; Sugiura Y; Maehara T
    Dis Esophagus; 2007; 20(2):94-101. PubMed ID: 17439591
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer.
    Stiles BM; Christos P; Port JL; Lee PC; Paul S; Saunders J; Altorki NK
    J Thorac Cardiovasc Surg; 2010 Feb; 139(2):387-94. PubMed ID: 20006355
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy and drawbacks of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the thoracic esophagus.
    Wolfárd A; Paszt A; Szentpáli K; Hideghéthy K; Uhercsák G; Németh I; Tiszlavicz L; Lázár G
    Hepatogastroenterology; 2011; 58(109):1214-9. PubMed ID: 21937381
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
    Yamamoto S; Ishihara R; Motoori M; Kawaguchi Y; Uedo N; Takeuchi Y; Higashino K; Yano M; Nakamura S; Iishi H
    Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
    J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognosis of esophageal cancer patients with pathologic complete response after preoperative concurrent chemoradiotherapy.
    Park JW; Kim JH; Choi EK; Lee SW; Yoon SM; Song SY; Lee YS; Kim SB; Park SI; Ahn SD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):691-7. PubMed ID: 20888705
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Using pretreatment tumor depth and length to select esophageal squamous cell carcinoma patients for nonoperative treatment after neoadjuvant chemoradiotherapy.
    Chao YK; Tseng CK; Wen YW; Liu YH; Wan YL; Chiu CT; Chang WC; Chang HK
    Ann Surg Oncol; 2013 Sep; 20(9):3000-8. PubMed ID: 23584515
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endoscopic tumor length is an independent prognostic factor in esophageal squamous cell carcinoma.
    Wang BY; Liu CY; Lin CH; Hsu PK; Hsu WH; Wu YC; Cheng CY
    Ann Surg Oncol; 2012 Jul; 19(7):2149-58. PubMed ID: 22407313
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic value of endoscopic biopsy findings after induction chemoradiotherapy with and without surgery for esophageal cancer.
    Miyata H; Yamasaki M; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Morii E; Mori M; Doki Y
    Ann Surg; 2011 Feb; 253(2):279-84. PubMed ID: 21169807
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The usefulness of neoadjuvant chemoradiation therapy for locally advanced esophageal cancer with multiple lymph-node metastases.
    Okumura H; Uchikado Y; Omoto I; Kita Y; Sasaki K; Arigami T; Uenosono Y; Matsushita D; Hiraki Y; Owaki T; Ishigami S; Natsugoe S
    Ann Surg Oncol; 2014 Sep; 21(9):2845-9. PubMed ID: 24728820
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The relationship of lymph node evaluation and colorectal cancer survival after curative resection: a multi-institutional study.
    Kanemitsu Y; Komori K; Ishiguro S; Watanabe T; Sugihara K
    Ann Surg Oncol; 2012 Jul; 19(7):2169-77. PubMed ID: 22302263
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion.
    de Manzoni G; Pedrazzani C; Pasini F; Bernini M; Minicozzi AM; Giacopuzzi S; Grandinetti A; Cordiano C
    J Surg Oncol; 2007 Mar; 95(3):261-6. PubMed ID: 17323341
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
    Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
    Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.
    Fujiwara Y; Yoshikawa R; Kamikonya N; Nakayama T; Kitani K; Tsujie M; Yukawa M; Inoue M; Yamamura T
    Oncol Rep; 2012 Aug; 28(2):446-52. PubMed ID: 22664791
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma.
    Chen J; Pan J; Liu J; Li J; Zhu K; Zheng X; Chen M; Chen M; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):671-7. PubMed ID: 23773390
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
    Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
    J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term survivors of esophageal carcinoma with distant lymph node metastasis.
    Okamura S; Fujiwara H; Shiozaki A; Komatsu S; Ichikawa D; Okamoto K; Murayama Y; Ikoma H; Kuriu Y; Nakanishi M; Ochiai T; Kokuba Y; Sonoyama T; Otsuji E
    Hepatogastroenterology; 2011; 58(106):421-5. PubMed ID: 21661407
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
    Reynolds JV; Donohoe CL; McGillycuddy E; Ravi N; O'Toole D; O'Byrne K; Hollywood D
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1130-1137.e1. PubMed ID: 22244551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.